Computational study of the phosphoryl transfer catalyzed by a cyclin-dependent kinase

被引:41
|
作者
De Vivo, Marco
Cavalli, Andrea
Carloni, Paolo
Recanatini, Maurizio
机构
[1] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy
[2] INFM Democritos, I-34014 Trieste, Italy
[3] ISAS, SISSA, Int Sch Adv Studies, I-34014 Trieste, Italy
关键词
density functional calculations; enzymatic catalysis; molecular dynamics; reaction mechanisms; transition state analogues;
D O I
10.1002/chem.200700044
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A cyclin-dependent kinase, Cdk2, catalyzes the transfer of the gamma-phosphate from ATP to a threonine or serine residue of its polypeptide substrates. Here, we investigate aspects of the reaction mechanism of Cdk2 by gas-phase density functional calculations, classical molecular dynamics, and Car-Parrinello QM/MM simulations. We focus on the role of the conserved Asp127 and on the nature of the phosphoryl transfer reaction mechanism catalyzed by Cdk2. Our findings suggest that Asp127 is active in its deprotonated form by assisting the formation of the near-attack orientation of the substrate serine or threonine. Therefore, the residue does not act as a general base during the catalysis. The mechanism for the phosphoryl transfer is a single S(N)2-like concerted step, which shows a phosphorane-like transition state geometry. Although the resulting reaction mechanism is in agreement with a previous density functional study of the same catalytic reaction mechanism (Cavalli et al., Chem. Comm. 2003, 1308-1309), the reaction barrier is considerably lower when QM/MM calculations are performed, as in this study (approximate to 42 kcalmol(-1) QM vs approximate to 24 kcalmol(-1) QM/MM); this indicates that important roles for the catalysis are played by the protein environment and solvent waters. Because of the high amino acid sequence conservation among the whole family of cyclin-dependent kinases (CDKs), these results could be general for the CDK family.
引用
收藏
页码:8437 / 8444
页数:8
相关论文
共 50 条
  • [21] Cyclins, Cyclin-Dependent Kinases, and Cyclin-Dependent Kinase Inhibitors in the Mouse Nervous System
    Alice Grison
    Suzana Atanasoski
    Molecular Neurobiology, 2020, 57 : 3206 - 3218
  • [22] Cyclin-dependent kinase inhibitors and hepatocarcinogenesis
    Hui, AM
    Sakamoto, M
    Kanai, Y
    Ino, Y
    Gotoh, M
    Hirohashi, S
    RECENT ADVANCES IN GASTROENTEROLOGICAL CARCINOGENESIS I, 1996, : 481 - 485
  • [23] A computational model of binding thermodynamics: The design of cyclin-dependent kinase 2 inhibitors
    Sims, PA
    Wong, CF
    McCammon, JA
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (15) : 3314 - 3325
  • [24] Expression of cyclin-dependent kinase 6, but not cyclin-dependent kinase 4, alters morphology of cultured mouse astrocytes
    Ericson, KK
    Krull, D
    Slomiany, P
    Grossel, MJ
    MOLECULAR CANCER RESEARCH, 2003, 1 (09) : 654 - 664
  • [25] Cyclins, cyclin-dependent kinases, cyclin-dependent kinase inhibitors and their role in head and neck cancer
    Jeannon, JP
    Wilson, JA
    CLINICAL OTOLARYNGOLOGY, 1998, 23 (05): : 420 - 424
  • [26] Changes in the activity of cyclin-dependent kinase 2 and cyclin-dependent kinase 5 accompany differentiation of rat primary oligodendrocytes
    Tang, XM
    Cambi, F
    Strocchi, P
    MOLECULAR BIOLOGY OF THE CELL, 1997, 8 : 120 - 120
  • [27] Cyclin-dependent kinase inhibitors for treating cancer
    Toogood, PL
    MEDICINAL RESEARCH REVIEWS, 2001, 21 (06) : 487 - 498
  • [28] Cyclin-dependent kinase inhibition in mesothelioma.
    Kratzke, Marian
    Kren, Betsy
    Porter, Stephen
    Scaria, George
    Klein, Mark A.
    CANCER RESEARCH, 2021, 81 (13)
  • [29] The cyclin-dependent kinase pathway moves forward
    Bornfeldt, KE
    CIRCULATION RESEARCH, 2003, 92 (04) : 345 - 347
  • [30] Mechanisms of cyclin-dependent kinase inactivation by progestins
    Musgrove, EA
    Swarbrick, A
    Lee, CSL
    Cornish, AL
    Sutherland, RL
    MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (04) : 1812 - 1825